Literature DB >> 7145836

Prenatal testing for inherited immune deficiencies by fetal blood sampling.

A Durandy, C Oury, C Griscelli, Y Dumez, J F Oury, R Henrion.   

Abstract

We attempted to develop a prenatal diagnosis in fetuses at risk for immunodeficiency by fetal blood sampling performed under fetoscopy at 18-22 weeks of gestation. In order to obtain normal values, we first investigated thirty-five control fetuses whose blood punctures were undertaken for the diagnosis of haemoglobinopathies. Surface markers and in vitro mitogen-induced proliferation of the fetal lymphocytes were studied using micromethods. We then examined two fetuses at risk for two different types of severe combined immunodeficiency and established their immunological integrity, hence avoiding an unjustified termination of pregnancy. This immunological integrity was confirmed after birth.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7145836     DOI: 10.1002/pd.1970020206

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  4 in total

1.  Fetal tissue sampling. The San Francisco experience with 190 pregnancies.

Authors:  M S Golbus; K F McGonigle; J D Goldberg; R A Filly; P W Callen; R L Anderson
Journal:  West J Med       Date:  1989-04

2.  Use of monoclonal antibodies in a study of the development of T lymphocytes in the human fetus.

Authors:  G E Asma; R L Van den Bergh; J M Vossen
Journal:  Clin Exp Immunol       Date:  1983-08       Impact factor: 4.330

3.  Rapid Flow cytometric prenatal diagnosis of primary immunodeficiency (PID) disorders.

Authors:  Anju Mishra; Maya Gupta; Aparna Dalvi; Kanjaksha Ghosh; Manisha Madkaikar
Journal:  J Clin Immunol       Date:  2014-02-18       Impact factor: 8.317

4.  Human leukocyte antigen typing using a knowledge base coupled with a high-throughput oligonucleotide probe array analysis.

Authors:  Guang Lan Zhang; Derin B Keskin; Hsin-Nan Lin; Hong Huang Lin; David S DeLuca; Scott Leppanen; Edgar L Milford; Ellis L Reinherz; Vladimir Brusic
Journal:  Front Immunol       Date:  2014-11-27       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.